Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 200

1.

Tumor Selective Silencing Using an RNAi-Conjugated Polymeric Nanopharmaceutical.

Svenson S, Case RI, Cole RO, Hwang J, Kabir SR, Lazarus D, Lim Soo P, Ng PS, Peters C, Shum P, Sweryda-Krawiec B, Tripathi S, van der Poll D, Eliasof S.

Mol Pharm. 2016 Mar 7;13(3):737-47. doi: 10.1021/acs.molpharmaceut.5b00608. Epub 2016 Feb 2.

PMID:
26835715
2.

Lipoarabinomannan, and its related glycolipids, induce divergent and opposing immune responses to Mycobacterium tuberculosis depending on structural diversity and experimental variations.

Källenius G, Correia-Neves M, Buteme H, Hamasur B, Svenson SB.

Tuberculosis (Edinb). 2016 Jan;96:120-30. doi: 10.1016/j.tube.2015.09.005. Epub 2015 Oct 28. Review.

PMID:
26586646
3.

The dendrimer paradox--high medical expectations but poor clinical translation.

Svenson S.

Chem Soc Rev. 2015 Jun 21;44(12):4131-44. doi: 10.1039/c5cs00288e. Review.

PMID:
25971933
4.

A sensitive urinary lipoarabinomannan test for tuberculosis.

Hamasur B, Bruchfeld J, van Helden P, Källenius G, Svenson S.

PLoS One. 2015 Apr 23;10(4):e0123457. doi: 10.1371/journal.pone.0123457. eCollection 2015.

5.

What nanomedicine in the clinic right now really forms nanoparticles?

Svenson S.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014 Mar-Apr;6(2):125-35. doi: 10.1002/wnan.1257. Epub 2014 Jan 10.

PMID:
24415653
6.

Pregnancy And Neonatal Diabetes Outcomes in Remote Australia (PANDORA) Study.

Maple-Brown LJ, Brown A, Lee IL, Connors C, Oats J, McIntyre HD, Whitbread C, Moore E, Longmore D, Dent G, Corpus S, Kirkwood M, Svenson S, van Dokkum P, Chitturi S, Thomas S, Eades S, Stone M, Harris M, Inglis C, Dempsey K, Dowden M, Lynch M, Boyle J, Sayers S, Shaw J, Zimmet P, O'Dea K.

BMC Pregnancy Childbirth. 2013 Dec 1;13:221. doi: 10.1186/1471-2393-13-221.

7.

Mycobacterium tuberculosis Strains Are Differentially Recognized by TLRs with an Impact on the Immune Response.

Carmona J, Cruz A, Moreira-Teixeira L, Sousa C, Sousa J, Osorio NS, Saraiva AL, Svenson S, Kallenius G, Pedrosa J, Rodrigues F, Castro AG, Saraiva M.

PLoS One. 2013 Jun 26;8(6):e67277. doi: 10.1371/journal.pone.0067277. Print 2013.

8.

Theranostics: are we there yet?

Svenson S.

Mol Pharm. 2013 Mar 4;10(3):848-56. doi: 10.1021/mp300644n. Epub 2013 Feb 4. Review.

PMID:
23379301
9.

Divergent effects of mycobacterial cell wall glycolipids on maturation and function of human monocyte-derived dendritic cells.

Mazurek J, Ignatowicz L, Kallenius G, Svenson SB, Pawlowski A, Hamasur B.

PLoS One. 2012;7(8):e42515. doi: 10.1371/journal.pone.0042515. Epub 2012 Aug 3.

10.

Molecular evidence of Plesiomonas shigelloides as a possible zoonotic agent.

González-Rey C, Siitonen A, Pavlova A, Ciznar I, Svenson SB, Krovacek K.

Folia Microbiol (Praha). 2011 Mar;56(2):178-84. doi: 10.1007/s12223-011-0032-2. Epub 2011 May 17.

PMID:
21584782
11.

Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101.

Svenson S, Wolfgang M, Hwang J, Ryan J, Eliasof S.

J Control Release. 2011 Jul 15;153(1):49-55. doi: 10.1016/j.jconrel.2011.03.007. Epub 2011 Mar 23.

12.

Towards new tuberculosis vaccines.

Svenson S, Källenius G, Pawlowski A, Hamasur B.

Hum Vaccin. 2010 Apr;6(4):309-17. Epub 2010 Apr 19. Review.

PMID:
20372087
13.

Epidemiology of Mycobacterium bovis infection in wild boar (Sus scrofa) from Portugal.

Santos N, Correia-Neves M, Ghebremichael S, Källenius G, Svenson SB, Almeida V.

J Wildl Dis. 2009 Oct;45(4):1048-61.

PMID:
19901381
14.

Dendrimers as versatile platform in drug delivery applications.

Svenson S.

Eur J Pharm Biopharm. 2009 Mar;71(3):445-62. doi: 10.1016/j.ejpb.2008.09.023. Epub 2008 Oct 17. Review.

PMID:
18976707
15.

Dendrimers for enhanced drug solubilization.

Svenson S, Chauhan AS.

Nanomedicine (Lond). 2008 Oct;3(5):679-702. doi: 10.2217/17435889.3.5.679. Review.

PMID:
18817470
16.

Mycobacterial glycoconjugates as vaccine candidates against tuberculosis.

Källenius G, Pawlowski A, Hamasur B, Svenson SB.

Trends Microbiol. 2008 Oct;16(10):456-62. doi: 10.1016/j.tim.2008.07.007. Epub 2008 Sep 4.

PMID:
18774297
17.

What are the effects of distance management on the retention of remote area nurses in Australia?

Weymouth S, Davey C, Wright JI, Nieuwoudt LA, Barclay L, Belton S, Svenson S, Bowell L.

Rural Remote Health. 2007 Jul-Sep;7(3):652. Epub 2007 Jul 31.

18.

Pathogen specific carbohydrate antigen microarrays: a chip for detection of Salmonella O-antigen specific antibodies.

Blixt O, Hoffmann J, Svenson S, Norberg T.

Glycoconj J. 2008 Jan;25(1):27-36. Epub 2007 Jun 9.

PMID:
17558551
19.

Should a new tuberculosis vaccine be administered intranasally?

Källenius G, Pawlowski A, Brandtzaeg P, Svenson S.

Tuberculosis (Edinb). 2007 Jul;87(4):257-66. Epub 2007 Feb 26. Review.

PMID:
17321797
20.

Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.

Tomalia DA, Reyna LA, Svenson S.

Biochem Soc Trans. 2007 Feb;35(Pt 1):61-7.

PMID:
17233602

Supplemental Content

Loading ...
Support Center